Osteogenic Differentiation in Healthy and Pathological Conditions
AbstractThis review focuses on the osteogenic differentiation of mesenchymal stem cells (MSC), bone formation and turn-over in good and ill skeletal fates. The interacting molecular pathways which control bone remodeling in physiological conditions during a lifelong process are described. Then, alterations of the molecular pathways regulating osteogenesis are addressed. In the aging process, as well as in glucocorticoid-induced osteoporosis, bone loss is caused not only by an unbalanced bone resorption activity, but also by an impairment of MSCs’ commitment towards the osteogenic lineage, in favour of adipogenesis. Mutations affecting the expression of key genes involved in the control of bone development occur in several heritable bone disorders. A few examples are described in order to illustrate the pathological consequences of perturbation in different steps of osteogenic commitment, osteoblast maturation, and matrix mineralization, respectively. The involvement of abnormal MSC differentiation in cancer is then discussed. Finally, a brief overview of clinical applications of MSCs in bone regeneration and repair is presented. View Full-Text
Share & Cite This Article
Valenti, M.T.; Dalle Carbonare, L.; Mottes, M. Osteogenic Differentiation in Healthy and Pathological Conditions. Int. J. Mol. Sci. 2017, 18, 41.
Valenti MT, Dalle Carbonare L, Mottes M. Osteogenic Differentiation in Healthy and Pathological Conditions. International Journal of Molecular Sciences. 2017; 18(1):41.Chicago/Turabian Style
Valenti, Maria T.; Dalle Carbonare, Luca; Mottes, Monica. 2017. "Osteogenic Differentiation in Healthy and Pathological Conditions." Int. J. Mol. Sci. 18, no. 1: 41.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.